Company: WHWK
Filing Date: 2025-05-08
Form Type: 8-K
Source: 0001628280-25-023788
Chunk: 1

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-05-08
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

  Exhibit Number      Description                                                                  
            99.1      Press Release, dated May 8, 2025                                             
 ───────────────────────────────────────────────────────────────────────────────────────────────────
             104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  May 8, 2025      /s/ Scott Giacobello     
 ────────────────────────────────────────────
                   Scott Giacobello         
                   Chief Financial Officer